
Dr
Hany
Zinad
Dr
Hany
Zinad
Postdoctoral Scientist
University od Oxfrod
Biography
I am currently a postdoctoral researcher at the University of Oxford, based in the Department of Biology. My research focuses on the development of a universal influenza vaccine, using a novel pipeline based on mathematical models of viral evolution. I am conducting pre-clinical studies involving murine immunisation models, applying both molecular immunology techniques and structural bioinformatics to evaluate the immunogenicity of a conserved influenza epitope.
Prior to this, I worked as a senior scientist in national healthcare institutions, contributing to the UK’s efforts in genomic surveillance of SARS-CoV-2. My role involved detecting and identifying emerging viral variants, supporting the public health response during the COVID-19 pandemic.
I completed my PhD in Biomedical Sciences and Genetics in 2020, where my research explored the regulatory roles of non-coding RNAs in infection and immunity. This work combined molecular biology, genetics, and immunology to better understand host-pathogen interactions and gene regulation.
Before starting my doctoral studies, I earned an MSc in Veterinary Microbiology in 2012, which deepened my interest in microbial pathogenesis and immune system dynamics. I also hold a Bachelor of Veterinary Medicine and Surgery (BVMS), awarded in 2008, where I graduated second in my cohort.
My scientific interests lie in the fields of molecular biology, immunology, and vaccine development. I am particularly focused on translational research that bridges molecular mechanisms and practical vaccine strategies, aiming to address global infectious disease challenges. Research interests
Molecular and cellular immunology, vaccinology, and host-pathogen interactions. I am particularly interested in how immune responses can be directed at the molecular level to provide broad and lasting protection, especially through targeting conserved viral elements. My research explores the role of non-coding RNAs in modulating immune responses, and how this knowledge can be applied to vaccine development.
I have a strong interest in both human and veterinary immunology, and in the translational aspects of vaccine research across species. My work reflects a “One Health” perspective—bridging animal and human models to improve our understanding of immune mechanisms and vaccine efficacy. Discipline
Bacteriology Cellular biology Challenge study design Epidemiology Immunology – B-cells Molecular biology Structural biology Virology Host species
Zoonoses Pathogen
Bacteria›Mycobacteria bovis Bacteria›Salmonella Viruses Viruses›Coronavirus Viruses›Influenza virus Viruses›Respiratory syncytial virus Stage of vaccine development
Pre-clinical trials